Becton Dickinson Pre-Tax Income 2010-2024 | BDX
Becton Dickinson annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Becton Dickinson pre-tax income for the quarter ending September 30, 2024 was $0.542B, a 199.45% increase year-over-year.
- Becton Dickinson pre-tax income for the twelve months ending September 30, 2024 was $2.034B, a 22.38% increase year-over-year.
- Becton Dickinson annual pre-tax income for 2024 was $2.033B, a 22.32% increase from 2023.
- Becton Dickinson annual pre-tax income for 2023 was $1.662B, a 6.79% decline from 2022.
- Becton Dickinson annual pre-tax income for 2022 was $1.783B, a 5.38% increase from 2021.
Becton Dickinson Annual Pre-Tax Income
(Millions of US $) |
| 2024 |
$2,033 |
| 2023 |
$1,662 |
| 2022 |
$1,783 |
| 2021 |
$1,692 |
| 2020 |
$414 |
| 2019 |
$1,176 |
| 2018 |
$1,173 |
| 2017 |
$976 |
| 2016 |
$1,074 |
| 2015 |
$739 |
| 2014 |
$1,522 |
| 2013 |
$1,165 |
| 2012 |
$1,472 |
| 2011 |
$1,618 |
| 2010 |
$1,567 |
| 2009 |
$1,579 |
Becton Dickinson Quarterly Pre-Tax Income
(Millions of US $) |
| 2024-09-30 |
$542 |
| 2024-06-30 |
$500 |
| 2024-03-31 |
$633 |
| 2023-12-31 |
$359 |
| 2023-09-30 |
$181 |
| 2023-06-30 |
$471 |
| 2023-03-31 |
$529 |
| 2022-12-31 |
$481 |
| 2022-09-30 |
$320 |
| 2022-06-30 |
$421 |
| 2022-03-31 |
$442 |
| 2021-12-31 |
$600 |
| 2021-09-30 |
$-148 |
| 2021-06-30 |
$378 |
| 2021-03-31 |
$305 |
| 2020-12-31 |
$1,157 |
| 2020-09-30 |
$-428 |
| 2020-06-30 |
$248 |
| 2020-03-31 |
$200 |
| 2019-12-31 |
$394 |
| 2019-09-30 |
$-1 |
| 2019-06-30 |
$460 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$714 |
| 2018-09-30 |
$415 |
| 2018-06-30 |
$647 |
| 2018-03-31 |
$6 |
| 2017-12-31 |
$105 |
| 2017-09-30 |
$326 |
| 2017-06-30 |
$-404 |
| 2017-03-31 |
$362 |
| 2016-12-31 |
$692 |
| 2016-09-30 |
$10 |
| 2016-06-30 |
$422 |
| 2016-03-31 |
$376 |
| 2015-12-31 |
$266 |
| 2015-09-30 |
$190 |
| 2015-06-30 |
$39 |
| 2015-03-31 |
$225 |
| 2014-12-31 |
$285 |
| 2014-09-30 |
$377 |
| 2014-06-30 |
$423 |
| 2014-03-31 |
$363 |
| 2013-12-31 |
$359 |
| 2013-09-30 |
$60 |
| 2013-06-30 |
$379 |
| 2013-03-31 |
$360 |
| 2012-12-31 |
$366 |
| 2012-09-30 |
$361 |
| 2012-06-30 |
$419 |
| 2012-03-31 |
$370 |
| 2011-12-31 |
$322 |
| 2011-09-30 |
$346 |
| 2011-06-30 |
$435 |
| 2011-03-31 |
$428 |
| 2010-12-31 |
$408 |
| 2010-09-30 |
$320 |
| 2010-06-30 |
$413 |
| 2010-03-31 |
$411 |
| 2009-12-31 |
$423 |
| 2009-09-30 |
$376 |
| 2009-06-30 |
$429 |
| 2009-03-31 |
$352 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
